|
Volumn 339, Issue 20, 1998, Pages
|
Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE;
CANCER STAGING;
EPIDEMIOLOGY;
HUMAN;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NONHODGKIN LYMPHOMA;
NOTE;
PROPORTIONAL HAZARDS MODEL;
SURVIVAL;
COMPARATIVE STUDY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HUMANS;
LYMPHOMA, NON-HODGKIN;
NEOPLASM STAGING;
PREDNISONE;
PROPORTIONAL HAZARDS MODELS;
SURVIVAL ANALYSIS;
VINCRISTINE;
|
EID: 0032511871
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|